SALLY CHUN: Open Payments
NPI 1912588187 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 61 payments from 16 companies in 2025. Trend: 2023 $1,132 · 2024 $818 · 2025 $1,510
Food & beverage: $1,411Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $246 |
| Regeneron Healthcare Solutions, Inc. | 6 | $200 |
| Incyte Corporation | 8 | $197 |
| Arcutis Biotherapeutics, Inc. | 8 | $174 |
| LEO Pharma Inc. | 4 | $105 |
| GENZYME CORPORATION | 3 | $90 |
| UCB, Inc. | 4 | $80 |
| Botanix SB Inc | 3 | $77 |
| Lilly USA, LLC | 2 | $58 |
| Organon LLC | 3 | $55 |
Products named: DUPIXENT, OPZELURA, Zoryve, COSENTYX, ADBRY, Bimzelx, SOFDRA, TALTZ.
Industry payments across NY — which companies pay providers there.
